F 0580
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Immediately tell the resident, the resident's doctor, and a family member of situations (injury/decline/room,
etc.) that affect the resident.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to immediately inform the resident, the resident
representative, and the resident's physician of a medication error and change in condition for 1 of 3
residents, Resident #1.
Findings include:
Review of the medical record for Resident #1 documented diagnosis to include type 2 diabetes mellitus and
diabetic neuropathy, chronic obstructive pulmonary disease, acute on chronic systolic (congestive) heart
failure, and primary essential hypertension.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Aspart Flexpen [a rapid-acting
human insulin to improve glycemic control, it works by replacing the insulin that is normally produced by the
body and by helping move sugar from the blood into other body tissues where it is used for energy]
Subcutaneous Solution Pen- injector 100 unit/ml [milliliter] inject 21 units subcutaneously before meals
related to type 2 diabetes mellitus with diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Glargine Solostar [an insulin
that is injected under the skin once daily and lasts in the body for about 24 hours used to control high blood
sugar to help prevent kidney damage, blindness, nerve problems, and loss of limbs; by replacing the insulin
that is normally produced by the body by helping move sugar from the blood into other body tissues where
it is used for energy] Subcutaneous Solution 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at
bedtime related to type 2 diabetes mellitus with diabetic neuropathy .
Review of the Medication Administration Record (MAR) for Resident #1 showed on 6/4/2023 at 6:00 AM,
Staff A, LPN (Licensed Practical Nurse), documented 9, other - see nurses notes, for Insulin Aspart
Flexpen.
Review of the nursing progress notes dated on and about 6/4/2023 did not contain documentation related
to Insulin Aspart Flexpen by any staff member to include Staff A, LPN.
Review of the change of condition SBAR (Situation, Background, Assessment and Recommendation)
dated 6/4/2023 at 2:13 PM for Resident #1 read, A. Situation . gave Lantus [Insulin Glargine] instead of
NovoLog [Insulin Aspart injection] this AM [morning]. This started on: 06/04/2023 . C. Review and Notify. 1.
Primary clinician notified: [Doctor's name]. 2. Date and Time notified: 06/04/2023 14:20 [2:20 PM]. 3.
Recommendations of Primary Clinician (if any): no new orders . 7. Nursing Notes (for
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 36
Event ID:
105846
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0580
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
additional information on the Change in Condition): Notified MD [Medical Doctor], no new orders, informed
him that family chose to take resident to ER [Emergency Room] in Gainesville.
Review of the nursing progress note authored by Staff B, Registered Nurse (RN), dated 6/4/2023 at 5:33
PM for Resident #1 read, Resident stated that the night nurse had given her the wrong insulin. She stated
that she told the nurse that it was the wrong insulin before the nurse gave it to her. Resident then
complained of having chest pains and a stomachache around 0800 [8:00 AM]. I checked the residents [Sic.]
blood sugar and it was 301. The residents [Sic.] daughter called facility upset and stated that no one
notified her of the medication error and that she was going to come take her mother to [hospital's name and
city of location] because she is too high risk to go to [local hospital's name]. The daughter told me to not
give her mother anymore insulin or medication until she takes her to [hospital's name]. The daughter also
stated that she was going to call the police and her attorney. At approximately 1130 [11:30 AM] the
daughter arrived with a police officer [Resident #1's name] walked out of the facility with her daughter at
approximately 1200 [noon].
During an interview on 6/19/2023 at 11:00 AM Staff I, Director of Nursing (DON) stated, This [medication
error] was not reported to the physician when this occurred by the night nurse at 6:15 AM. It was not
reported until about 11:30 in the morning. She came back in when [Assistant Director of Nursing's name]
got hold of her. The staff should have called the doctor when the mistake occurred and obtained orders
then. I can't tell you why she didn't. I'm not sure when the day shift nurse found out about the error. They
just don't know or have any common sense that would make them call the doctor. They clearly don't
understand the difference between long and short acting insulins. I guess we need to train them.
During an interview on 6/19/2023 at 11:41 AM, Staff A, LPN, stated, I was helping out that night. I usually
work days and usually work the LTC [long term care] unit and picked up a shift. I read her order and she
had two different insulins. One insulin looked like it was in the wrong bag. I thought it was too much insulin, I
gave it, the long acting the Lantus. Then I reread the order after the resident told me she didn't get that kind
until the night. After that I just waited for the day nurse. I did not notify the doctor. I guess I just didn't think it
was necessary and then I spoke with the day nurse, and she didn't say to call the doctor. She said, well we
will just wait and see what her blood sugar does. I should have called. [Assistant Director of Nursing's
name] messaged me and asked about it. I told him what happened and came in to write the progress note
and I called the doctor then. I explained what happened. He did not give any new orders because the
resident was leaving with her daughter, who was taking her to the hospital. I did tell the oncoming nurse
and she didn't seem too concerned because it was a long-acting insulin. She did not tell me to call the
doctor before I left. The resident said to me after I told her what I administered that she took that [Lantus
insulin] at night not in the morning. I double checked the MAR and saw she was right. She had been given
her Lantus the evening before. I just didn't think about it at all.
During a telephone interview on 6/19/2023 at 11:50 AM, Staff B, RN, stated, I came on shift and the night
shift nurse told me she had given the wrong insulin. I didn't tell her to call the doctor, said she notified him.
At about 8 AM [Resident #1's name] was going to breakfast, and she told me about the med error. At that
time, she was complaining she was weak and had a stomachache. I didn't check her blood sugar then; she
was going to eat, and I told her if she didn't feel better to let me know. When she was coming back from
breakfast, she was still feeling that way, so I got her to lay down. I went to do something else with another
resident and then her daughter was on the phone, and I spoke to her. She was very upset, so I talked to
her. After I got off the phone, I checked her insulin, and it was 301 at that time. After that, I spoke with her
daughter and her daughter insisted I not
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 2 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0580
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
give her anything more and stated she would take her to the ER because she didn't want her to go to
anywhere but [hospital's name]. She told another nurse she was having chest pain sometime around then,
but I wasn't worried about chest pain. I don't know why. I guess because her daughter was going to take her
to the ER. I did not call the doctor about the chest pain or any other symptoms that she had. I should have
called him. He was going to send her out and they would take her to [hospital's name] and I knew her
daughter didn't want her to go there and so I just didn't think to call and notify him. I did not think to call 911
and let the resident or daughter refuse to go to the hospital. I should have.
During a telephone interview on 6/19/2023 at 12:10 PM, the MD stated, I was not notified of this error when
it occurred. I absolutely should have been notified and I would have ordered more frequent blood sugars to
determine if there was a pattern of hypoglycemia [low blood sugar] and we would have been able to treat
any potential hypoglycemic events. I was not aware that she had any episodes of chest pain or pressure,
fatigue or abdominal discomfort. Again, I should have been notified and I would have had them send her to
the hospital.
During a telephone interview on 6/19/2023 at 12:30 PM, Resident #1 stated, I was having chest pain,
sweating, and nausea when I left [NAME] Pointe because I was given the wrong insulin. So, my daughter
brought me to [hospital's name] ED [Emergency Department]. I am still in the hospital now. But I'm not
feeling too good. I don't think that my blood sugar was too low when I got to the hospital. I told them that
they were giving me the wrong kind of insulin, but they didn't listen. They did not check my blood sugar after
they did that. I told them when I went to breakfast that I wasn't feeling good, but they didn't listen. After
breakfast, I told them again that I was having chest pains and feeling dizzy and nauseous, but they didn't
listen until my daughter called. After that is when they checked on me.
During an interview on 6/19/2023 at 1:41 PM, the Assistant Director of Nursing (ADON) stated, I was on
call that day and don't remember what exact time I was called. Staff told me that the resident was being
taken to the emergency room and that there had been a med error and what the error was. That the error
was that Lantus had been given instead of the ordered insulin. I contacted the nurse, [Staff A's name],
asked what happened. She explained everything. She did let me know that she had not contacted the
doctor or completed any documentation. I told her that she needed to make sure she had an SBAR and MD
notification documented. She stated she would come here immediately and come work on it. She should
have immediately called the physician. I found out that the patient had chest pain also and that's why the
family was so upset. We should have documented any symptoms and called the physician when she was
having chest pain, and got an order to leave to the ED. If her daughter refused, because she didn't want to
go to the nearest hospital, then she refused. But we did not call and get orders to send her out of the facility
to the hospital and we should have.
Review of the policy and procedure titled Administering Medications revised in April 2019 and last approved
on 10/16/2022 read, Policy Statement: Medications are administered in a safe and timely manner, and as
prescribed. Policy Interpretation and Implementation . 4. Medications are administered in accordance with
prescriber orders, including any required time frame. 5. Medication administration times are determined by
resident need and benefit, not staff convenience. Factors that are considered include: a. Enhancing optimal
therapeutic effect of the medication . 6. Medication errors are documented, reported, and reviewed by the
QAPI [Quality Assurance Performance Improvement] committee to inform process changes and or the
need for additional staff training . 10. The individual administering the medication checks the label THREE
(3) times to verify the right resident, right medication, right dosage, right time and right method (route) of
administration before giving the medication.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 3 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0580
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Review of the policy and procedure titled Notification of Change in Condition with a revision date of
12/16/2020, read, Policy: The center to promptly notify the Patient/Resident, the attending physician, and
the Resident Representative when there is a change in the status or condition. Procedure: The nurse to
notify the attending physician and Resident Representative when there is a(n): Accidents, Significant
change in the patient/ resident's physical, mental, or psychosocial status, Need to alter treatment
significantly, New treatment, Discontinuation of a current treatment due to but not limited to: Adverse
consequences, Acute condition, Exacerbation of a chronic condition . The nurse to complete an evaluation
of the Patient/Resident. Document evaluation in the medical record. The nurse will contact the physician. In
the event that the attending physician does not respond in a reasonable amount of time, the Medical
Director may be contacted . Complete SBAR as indicated.
Event ID:
Facility ID:
105846
If continuation sheet
Page 4 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Protect each resident from all types of abuse such as physical, mental, sexual abuse, physical punishment,
and neglect by anybody.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews with a resident and staff, resident record reviews and review of the facility policies and
procedures, the facility failed to ensure residents were free from medical neglect when the staff failed to
follow physicians' orders, resulting in insulin medication errors for 6 of 7 residents, Residents #1, #2, #3, #4,
#5, and #6. Resident #1 was administered the wrong insulin and Residents #2, #3, #4, #5, and #6 were not
administered physician ordered long-acting insulin. The body must have insulin working 24 hours a day. If
there is no long-acting insulin administered and rapid acting insulin is not given within the past 3-4 hours, it
is likely that the body will make ketones and will be at risk of developing life-threatening diabetic
ketoacidosis (DKA) or Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS). Extremely high blood
glucose can lead to Hyperosmolar Hyperglycemic Nonketotic Coma (HHNK), a life-threatening complication
of uncontrolled diabetes mellitus. This syndrome is characterized by severe hyperglycemia, a marked
increase in serum osmolality, and clinical evidence of dehydration without significant accumulation of keto
acids, which can result when diabetic medications aren't taken as directed. DKA is caused by an overload
of ketones present in your blood. When the cells don't get the glucose they need for energy, the body
begins to burn fat for energy, which produces ketones. Ketones are chemicals that the body creates when it
breaks down fat to use for energy. DKA is a life-threatening problem that affects people with diabetes. It
occurs when the body starts breaking down fat at a rate that is much too fast. The liver processes the fat
into a fuel called ketones, which causes the blood to become acidic.
Findings include:
Review of the medical record for Resident #6 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #6 dated 7/13/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml [milliliter] (Insulin Glargine) inject 10 units subcutaneously in the morning
related to type 2 diabetes mellitus without complications.
Review of the physician orders for Resident #6 dated 7/14/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the Medication Administration Record (MAR) for Resident #6 for the period of 4/1/2023 to
7/5/2023 showed on 4/1/2023 at 6:00 AM, Staff D, LPN (Licensed Practical Nurse) documented 11 (held
per parameters) for Lantus Insulin, 4/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/2/23 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for
Lantus Insulin, 4/3/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/4/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/4/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/5/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/7/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/8/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/9/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/10/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 5 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
parameters) for Lantus Insulin, 4/13/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/14/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at
6:00 AM, Staff, C LPN, documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/19/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/21/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/22/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/23/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/23/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/24/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/26/2023 at
9:00 PM, Staff, C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/27/2023 at 6:00 AM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/27/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/28/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/2/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/5/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/6/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/8/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/11/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/12/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/15/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/24/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/3/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/5/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/6/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/7/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/14/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 6/14/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin,
6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/20/2023 at
6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/21/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/21/2023 at 9:00 PM, Staff, D LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/22/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 7/1/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 7/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 7/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin.
Review of the medical record for Resident #4
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 6 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
documented diagnosis to include type 2 diabetes mellitus.
Level of Harm - Immediate
jeopardy to resident health or
safety
Review of the physician orders for Resident #4 dated 3/7/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to Type
2 diabetes mellitus without complications.
Residents Affected - Some
Review of the MAR for Resident #4 for the period of 4/1/2023 to 7/5/2023 showed on 4/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/3/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/4/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 4/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/18/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/21/2023 at 9:00
PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/22/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/23/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/26/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/27/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 5/1/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 5/2/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/5/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 5/6/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
5/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/25/2023
at 9:00 PM, Staff A, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/2/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/3/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 6/5/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 6/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 6/20/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen,
6/21/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/26/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 7/1/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #5 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #5 dated 4/5/2023 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 45 units subcutaneously every morning and at
bedtime related to type 2 diabetes mellitus without complications.
Review of the MAR for Resident #5 for the period of 4/1/2023 to 7/5/2023 showed on 4/7/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/8/2023 at 8:00 PM,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 7 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/9/2023 at 6:00 AM, Staff E, LPN,
documented 12 (insulin not required) for Lantus Solostar, 4/11/2023 at 8:00 PM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 4/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 4/13/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required)
for Lantus Solostar, 4/13/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 4/17/2023 at 6:00 AM, Staff F, LPN, documented 12 (insulin not required) for Lantus Solostar,
4/18/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/19/2023 at
6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/21/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 4/21/2023 at 8:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Lantus Solostar, 4/22/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/23/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/25/2023 at 8:00 PM, Staff G, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/26/2023 at 6:00 AM, Staff G, LPN,
documented 5 (hold see nurses notes) for Lantus Solostar, 4/27/2023 at 6:00 AM, Staff E, LPN,
documented 11 (held per parameters) for Lantus Solostar, 5/2/2023 at 6:00 AM, Staff E, LPN, documented
11 (held per parameters) for Lantus Solostar, 5/5/2023 at 8:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Solostar, 5/6/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Solostar, 5/11/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 5/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
5/15/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/17/2023 at
6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/20/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 6/2/2023 at 8:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 6/3/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Solostar, 6/9/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 6/13/2023 at 6:00 AM, Staff H, LPN, documented 12 (insulin not required)
for Lantus Solostar, 6/15/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Solostar, 6/19/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar,
6/23/2023 at 6:00 AM, Staff H, LPN, documented 9 (other see nursing note) for Lantus Solostar, 6/30/2023
at 8:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Solostar, 7/1/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar.
Review of the medical record for Resident #2 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #2 dated 4/6/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the MAR for Resident #2 for the period of 6/1/2023 to 6/19/2023 showed on 6/6/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/14/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #3 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #3 dated 3/10/2023 read, Insulin Glargine Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 35 units subcutaneously at bedtime related to
Type 2 diabetes mellitus without complications.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 8 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Review of the MAR for Resident #3 for the period of 5/1/2023 to 6/19/2023 showed on 5/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/6/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/20/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/29/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/4/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/8/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin.
Review of the medical record for Resident #1 documented diagnosis to include type 2 diabetes mellitus and
diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Aspart Flexpen Subcutaneous
Solution Pen- injector 100 unit/ml (Insulin Aspart) inject 21 units subcutaneously before meals related to
type 2 diabetes mellitus with diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Glargine Solostar
Subcutaneous Solution Pen- injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at
bedtime related to type 2 diabetes mellitus with diabetic neuropathy.
Review of the MAR for Resident #1 for the period of 6/1/2023 to 6/4/2023 showed on 6/4/2023 at 6:00 AM,
Staff A, LPN, documented 9 (other see nurses notes).
Review of the nursing progress notes did not reveal a progress note on 6/4/2023 for 6:00 AM written by
Staff A, LPN.
Review of the change of condition SBAR (Situation, Background, Assessment and Recommendation)
dated 6/4/2023 at 2:13 PM for Resident #1 read, A. Situation: 1 . gave Lantus instead of NovoLog this AM
[morning]. 2. This started on: 06/04/2023 . C. Review and Notify. 1. Primary clinician notified: [Doctor's
name]. 2. Date and Time notified: 06/04/2023 14:20 [2:20 PM]. 3. Recommendations of Primary Clinician (if
any): no new orders . 7. Nursing Notes (for additional information on the Change in Condition): Notified MD
[Medical Doctor], no new orders, informed him that family chose to take resident to ER [Emergency Room]
in Gainesville.
Review of the nursing progress note authored by Staff B, Registered Nurse (RN), dated 6/4/2023 at 5:33
PM for Resident #1 read, Resident stated that the night nurse had given her the wrong insulin. She stated
that she told the nurse that it was the wrong insulin before the nurse gave it to her. Resident then
complained of having chest pains and a stomachache around 0800 [8:00 AM]. I checked the residents [Sic.]
blood sugar and it was 301. The residents [Sic.] daughter called facility upset and stated that no one
notified her of the medication error and that she was going to come take her mother to [hospital's name and
city of location] because she is too high risk to go to [local hospital's name]. The daughter told me to not
give her mother anymore insulin or medication until she takes
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 9 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
her to [hospital's name]. The daughter also stated that she was going to call the police and her attorney. At
approximately 1130 [11:30 AM] the daughter arrived with a police officer [Resident #1's name] walked out
of the facility with her daughter at approximately 1200 [noon].
During an interview on 6/19/2023 at 11:00 AM, Staff I, Director of Nursing (DON), stated, Insulin is a
high-risk medication that an error can cause problems with low blood sugars or with high blood sugars if
they administer too much, the wrong kind or none. I was not aware that nurses were not administering
insulin and documenting that it was being held because of parameters. There are no parameters for
long-acting insulins in the residents' records. They should be administering these or at the very least calling
and asking the doctor if they should administer the insulin when they do accuchecks [blood sugar
monitoring]. This [medication error] was not reported to the physician when this occurred by the night nurse
at 6:15 AM. It was not reported until about 11:30 in the morning. She came back in when [Assistant Director
of Nursing's name] got hold of her. The staff should have called the doctor when the mistake occurred and
obtained orders then. I can't tell you why she didn't. I'm not sure when the day shift nurse found out about
the error. We did not look at all the residents' receiving insulin when the medication error was made. I didn't
know that I needed to evaluate anyone else after [Staff A's name] made the mistake. They just don't know
or have any common sense that would make them call the doctor. They clearly don't understand the
difference between long and short acting insulins. I guess we need to train them.
During an interview on 6/19/2023 at 11:41 AM, Staff A, LPN, stated, I was helping out that night. I usually
work days and usually work the LTC [long term care] unit and picked up a shift. I read her order and she
had two different insulins. One insulin looked like it was in the wrong bag. I thought it was too much insulin, I
gave it, the long acting the Lantus. Then I reread the order after the resident told me she didn't get that kind
until the night. After that I just waited for the day nurse. I did not notify the doctor. I guess I just didn't think it
was necessary and then I spoke with the day nurse, and she didn't say to call the doctor. She said, well we
will just wait and see what her blood sugar does. I should have called. [Assistant Director of Nursing's
name] messaged me and asked about it. I told him what happened and came in to write the progress note
and I called the doctor then. I explained what happened. He did not give any new orders because the
resident was leaving with her daughter, who was taking her to the hospital. I did tell the oncoming nurse
and she didn't seem too concerned because it was a long-acting insulin. She did not tell me to call the
doctor before I left. The resident said to me after I told her what I administered that she took that [Lantus
insulin] at night not in the morning. I double checked the MAR and saw she was right. She had been given
her Lantus the evening before. I just didn't think about it at all.
During a telephone interview on 6/19/2023 at 11:50 AM, Staff B, RN, stated, I came on shift and the night
shift nurse told me she had given the wrong insulin. I didn't tell her to call the doctor, said she notified him.
At about 8 AM [Resident #1's name] was going to breakfast, and she told me about the med error. At that
time, she was complaining she was weak and had a stomachache. I didn't check her blood sugar then; she
was going to eat, and I told her if she didn't feel better to let me know. When she was coming back from
breakfast, she was still feeling that way, so I got her to lay down. I went to do something else with another
resident and then her daughter was on the phone, and I spoke to her. She was very upset, so I talked to
her. After I got off the phone, I checked her insulin, and it was 301 at that time. After that, I spoke with her
daughter and her daughter insisted I not give her anything more and stated she would take her to the ER
because she didn't want her to go to anywhere but [hospital's name]. She told another nurse she was
having chest pain sometime around then, but I wasn't worried about chest pain. I don't know why. I guess
because her daughter was
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 10 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
going to take her to the ER. I did not call the doctor about the chest pain or any other symptoms that she
had. I should have called him. He was going to send her out and they would take her to [hospital's name]
and I knew her daughter didn't want her to go there and so I just didn't think to call and notify him. I did not
think to call 911 and let the resident or daughter refuse to go to the hospital. I should have.
During a telephone interview on 6/19/2023 at 12:10 PM, the MD stated, I was not notified of this error when
it occurred. I absolutely should have been notified and I would have ordered more frequent blood sugars to
determine if there was a pattern of hypoglycemia [low blood sugar] and we would have been able to treat
any potential hypoglycemic events. I was not aware that she had any episodes of chest pain or pressure,
fatigue or abdominal discomfort. Again, I should have been notified and I would have had them send her to
the hospital.
During a telephone interview on 6/19/2023 at 12:30 PM, Resident #1 stated, I was having chest pain,
sweating, and nausea when I left [NAME] Pointe because I was given the wrong insulin. So, my daughter
brought me to [hospital's name] ED [Emergency Department]. I am still in the hospital now. But I'm not
feeling too good. I don't think that my blood sugar was too low when I got to the hospital. I told them that
they were giving me the wrong kind of insulin, but they didn't listen. They did not check my blood sugar after
they did that. I told them when I went to breakfast that I wasn't feeling good, but they didn't listen. After
breakfast, I told them again that I was having chest pains and feeling dizzy and nauseous, but they didn't
listen until my daughter called. After that is when they checked on me.
During an interview on 6/19/2023 at 1:41 PM, the Assistant Director of Nursing (ADON) stated, I was on
call that day and don't remember what exact time I was called. Staff told me that the resident was being
taken to the emergency room and that there had been a med error and what the error was. That the error
was that Lantus had been given instead of the ordered insulin. I contacted the nurse, [Staff A's name],
asked what happened. She explained everything. She did let me know that she had not contacted the
doctor or completed any documentation. I told her that she needed to make sure she had an SBAR and MD
notification documented. She stated she would come here immediately and come work on it. She should
have immediately called the physician. I found out that the patient had chest pain also and that's why the
family was so upset. We should have documented any symptoms and called the physician when she was
having chest pain, and got an order to leave to the ED. If her daughter refused, because she didn't want to
go to the nearest hospital, then she refused. But we did not call and get orders to send her out of the facility
to the hospital and we should have.
During an interview conducted on 6/19/2023 at 3:20 PM, Staff I, Director of Nursing (DON), stated, Each
time 11 is documented the medication was not given per parameters, the nurses did not administer the
long-acting insulin. Reviewing the orders, I see that there are no parameters to hold the medication and the
insulin should have been administered. They were not following doctors' orders. They were not following the
policies for medication administration and holding medications. They should have called the doctor if they
were concerned about administering the medications. I have no idea why they would have held the insulin. I
guess this is an education thing. They just don't know any better. I just don't know why they did this.
During a telephone interview on 7/5/2023 at 2:10 PM, Staff C, LPN, stated, I was not really given a good
in-service about insulin or medication errors. She told me to sign a piece of paper, the other DON. I did not
get any text messages. I didn't know that we shouldn't hold the insulin, that we needed parameters to hold
it. My understanding was that anything under 150, we should not administer
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 11 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0600
Level of Harm - Immediate
jeopardy to resident health or
safety
the insulin. I guess I just assumed that from the sliding scales maybe. Also, I was holding some insulin
when residents didn't want to take it because they knew that would make them drop lower and I was
documenting it as 11, which is wrong, and they told me in the in-service today. I did come in today and have
the in-service with the DON. We went over neglect, insulin long and short acting, parameters with short
acting, that we will call doctors if we have concerns, changes in condition, medication errors and making
sure we notify doctors and families. We did an insulin demonstration too.
Residents Affected - Some
During a telephone interview on 7/5/2023 at 2:35 PM, Staff D, LPN, stated, I did hold insulin for low blood
sugars. Just through the years I was told that if the blood sugars are less than 150 not to administer the
insulin because it would drop it lower. I did not have a doctor's order to hold the insulin and I did not call
when I wasn't giving the insulin. I should have administered the insulin if there were no parameters to hold
it. I was not following doctors' orders when I held those insulins if there were no parameters written in the
orders.
During an interview on 7/6/2023 at 10:35 AM, the MD stated, I was not aware that nurses were holding
long-acting insulins outside of my written parameters. I write an order for accuchecks and to be notified if
they are below 60 or above 400. I do not write specific hold orders. I expect them to administer the insulin. If
they are symptomatic meaning, they are dizzy, lightheaded, I expect to be called and notified. I do expect
the staff to inform me anytime they hold medications. The risk of not administering long-acting insulin would
most obviously be hyperglycemia, going into HHNK if they have any infection brewing. It is and can be
catastrophic in the right setting. Residents would need to get hospitalized if the hyperglycemia were severe
enough, they risk dehydration with persistent hyperglycemia and diabetics poorly controlled are at risk for
worsening kidney failure, electrolyte abnormalities, worsening eyesight, worsening peripheral neuropathy,
coma and sometimes death. We need to provide this education and training to the nurses.
During a telephone interview on 7/6/2023 at 11:00 AM, Staff E, LPN, stated, I was holding the Levemir and
Lantus and would document that insulin was not needed because blood sugars were low. They weren't
really low, not in the 50s, but below 150. I didn't know I wasn't supposed to do that. I did not call or notify the
doctor when I held those. I should have. There were not any parameters to hold the insulin. I was not
following the doctors' orders. I should have followed the orders. I thought I was doing the right thing. I would
never want to hurt anyone at all. I was provided one on one education about neglect, long and short acting
insulin, what parameters are for holding insulin, calling doctors with any time we need to hold medications,
or they are refused, changes in condition notifications, medication errors and reporting them to doctors. We
had to do an insulin and five rights of medication administration demonstration for the DON.
During a telephone interview on 7/6/2023 at 11:30 AM, Staff F, LPN, stated, I did hold insulin when the
blood sugars were low, less than 150. I was taught that we don't give insulin for anything less than 150. I
don't think that the orders had any parameters from the doctor. I did not call the doctor and I would have
documented if they had any symptoms. There were no orders to hold the insulin, I was not following
doctors' orders. I should have given the insulin and followed the orders. I have been in-serviced today on
neglect, the f[TRUNCATED]
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 12 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Immediate
jeopardy to resident health or
safety
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews with a resident and staff, resident record reviews and review of the facility policies and
procedures, the facility failed to ensure the residents who required insulin administration received treatment
in accordance with professional standards of practice by administering the wrong insulin and/or failing to
administer long-acting insulin per physician orders for 6 of 7 residents receiving insulin, Residents #1, #2,
#3, #4, #5 and #6. The body must have insulin working 24 hours a day. If there is no long-acting insulin
administered and rapid acting insulin is not given within the past 3-4 hours, it is likely that the body will
make ketones and will be at risk of developing life-threatening diabetic ketoacidosis (DKA) or
Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS). Extremely high blood glucose can lead to
Hyperosmolar Hyperglycemic Nonketotic Coma (HHNK), a life-threatening complication of uncontrolled
diabetes mellitus. This syndrome is characterized by severe hyperglycemia, a marked increase in serum
osmolality, and clinical evidence of dehydration without significant accumulation of keto acids, which can
result when diabetic medications aren't taken as directed. DKA is caused by an overload of ketones present
in your blood. When the cells don't get the glucose they need for energy, the body begins to burn fat for
energy, which produces ketones. Ketones are chemicals that the body creates when it breaks down fat to
use for energy. DKA is a life-threatening problem that affects people with diabetes. It occurs when the body
starts breaking down fat at a rate that is much too fast. The liver processes the fat into a fuel called ketones,
which causes the blood to become acidic.
Residents Affected - Some
Findings include:
Review of the medical record for Resident #6 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #6 dated 7/13/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml [milliliter] (Insulin Glargine) inject 10 units subcutaneously in the morning
related to type 2 diabetes mellitus without complications.
Review of the physician orders for Resident #6 dated 7/14/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the Medication Administration Record (MAR) for Resident #6 for the period of 4/1/2023 to
7/5/2023 showed on 4/1/2023 at 6:00 AM, Staff D, LPN (Licensed Practical Nurse) documented 11 (held
per parameters) for Lantus Insulin, 4/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/2/23 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for
Lantus Insulin, 4/3/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/4/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/4/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/5/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/7/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/8/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/9/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/10/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/13/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 13 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
for Lantus Insulin, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/14/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at
6:00 AM, Staff, C LPN, documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/19/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/21/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/22/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/23/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/23/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/24/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/26/2023 at
9:00 PM, Staff, C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/27/2023 at 6:00 AM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/27/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/28/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/2/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/5/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/6/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/8/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/11/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/12/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/15/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/24/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/3/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/5/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/6/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/7/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/14/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 6/14/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin,
6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/20/2023 at
6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/21/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/21/2023 at 9:00 PM, Staff, D LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/22/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 7/1/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 7/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 7/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin.
Review of the medical record for Resident #4 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #4
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 14 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
dated 3/7/2023 read, Levemir Flexpen Subcutaneous Solution Pen-injector 100 unit/ml (Insulin Detemir)
inject 35 units subcutaneously at bedtime related to Type 2 diabetes mellitus without complications.
Review of the MAR for Resident #4 for the period of 4/1/2023 to 7/5/2023 showed on 4/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/3/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/4/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 4/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/18/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/21/2023 at 9:00
PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/22/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/23/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/26/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/27/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 5/1/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 5/2/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/5/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 5/6/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
5/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/25/2023
at 9:00 PM, Staff A, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/2/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/3/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 6/5/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 6/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 6/20/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen,
6/21/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/26/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 7/1/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #5 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #5 dated 4/5/2023 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 45 units subcutaneously every morning and at
bedtime related to type 2 diabetes mellitus without complications.
Review of the MAR for Resident #5 for the period of 4/1/2023 to 7/5/2023 showed on 4/7/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/8/2023 at 8:00 PM, Staff E, LPN,
documented 12 (insulin not required) for Lantus Solostar, 4/9/2023 at 6:00 AM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 4/11/2023 at 8:00 PM, Staff E, LPN,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 15 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
documented 12 (insulin not required) for Lantus Solostar, 4/12/2023 at 6:00 AM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 4/13/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 4/13/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required)
for Lantus Solostar, 4/17/2023 at 6:00 AM, Staff F, LPN, documented 12 (insulin not required) for Lantus
Solostar, 4/18/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
4/19/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/21/2023 at
6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 4/21/2023 at 8:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 4/22/2023 at 6:00 AM, Staff D,
LPN, documented 11 (held per parameters) for Lantus Solostar, 4/23/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/25/2023 at 8:00 PM, Staff G, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/26/2023 at 6:00 AM, Staff G, LPN,
documented 5 (hold see nurses notes) for Lantus Solostar, 4/27/2023 at 6:00 AM, Staff E, LPN,
documented 11 (held per parameters) for Lantus Solostar, 5/2/2023 at 6:00 AM, Staff E, LPN, documented
11 (held per parameters) for Lantus Solostar, 5/5/2023 at 8:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Solostar, 5/6/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Solostar, 5/11/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 5/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
5/15/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/17/2023 at
6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/20/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 6/2/2023 at 8:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 6/3/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Solostar, 6/9/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 6/13/2023 at 6:00 AM, Staff H, LPN, documented 12 (insulin not required)
for Lantus Solostar, 6/15/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Solostar, 6/19/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar,
6/23/2023 at 6:00 AM, Staff H, LPN, documented 9 (other see nursing note) for Lantus Solostar, 6/30/2023
at 8:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Solostar, 7/1/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar.
Review of the medical record for Resident #2 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #2 dated 4/6/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the MAR for Resident #2 for the period of 6/1/2023 to 6/19/2023 showed on 6/6/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/14/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #3 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #3 dated 3/10/2023 read, Insulin Glargine Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 35 units subcutaneously at bedtime related to
Type 2 diabetes mellitus without complications.
Review of the MAR for Resident #3 for the period of 5/1/2023 to 6/19/2023 showed on 5/1/2023 at
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 16 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/2/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/6/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/20/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/29/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/4/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/2/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/8/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/12/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin.
Review of the medical record for Resident #1 documented diagnosis to include type 2 diabetes mellitus and
diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Aspart Flexpen Subcutaneous
Solution Pen- injector 100 unit/ml (Insulin Aspart) inject 21 units subcutaneously before meals related to
type 2 diabetes mellitus with diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Glargine Solostar
Subcutaneous Solution Pen- injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at
bedtime related to type 2 diabetes mellitus with diabetic neuropathy.
Review of the MAR for Resident #1 for the period of 6/1/2023 to 6/4/2023 showed on 6/4/2023 at 6:00 AM,
Staff A, LPN, documented 9 (other see nurses notes).
Review of the nursing progress notes did not reveal a progress note on 6/4/2023 for 6:00 AM written by
Staff A, LPN.
Review of the change of condition SBAR (Situation, Background, Assessment and Recommendation)
dated 6/4/2023 at 2:13 PM for Resident #1 read, A. Situation: 1 . gave Lantus instead of NovoLog this AM
[morning]. 2. This started on: 06/04/2023 . C. Review and Notify. 1. Primary clinician notified: [Doctor's
name]. 2. Date and Time notified: 06/04/2023 14:20 [2:20 PM]. 3. Recommendations of Primary Clinician (if
any): no new orders . 7. Nursing Notes (for additional information on the Change in Condition): Notified MD
[Medical Doctor], no new orders, informed him that family chose to take resident to ER [Emergency Room]
in Gainesville.
Review of the nursing progress note authored by Staff B, Registered Nurse (RN), dated 6/4/2023 at 5:33
PM for Resident #1 read, Resident stated that the night nurse had given her the wrong insulin. She stated
that she told the nurse that it was the wrong insulin before the nurse gave it to her. Resident then
complained of having chest pains and a stomachache around 0800 [8:00 AM]. I checked the residents [Sic.]
blood sugar and it was 301. The residents [Sic.] daughter called facility upset and stated that no one
notified her of the medication error and that she was going to come take her mother to [hospital's name and
city of location] because she is too high risk to go to [local hospital's name]. The daughter told me to not
give her mother anymore insulin or medication until she takes her to [hospital's name]. The daughter also
stated that she was going to call the police and her
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 17 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
attorney. At approximately 1130 [11:30 AM] the daughter arrived with a police officer [Resident #1's name]
walked out of the facility with her daughter at approximately 1200 [noon].
During an interview on 6/19/2023 at 11:00 AM, Staff I, Director of Nursing (DON), stated, Insulin is a
high-risk medication that an error can cause problems with low blood sugars or with high blood sugars if
they administer too much, the wrong kind or none. I was not aware that nurses were not administering
insulin and documenting that it was being held because of parameters. There are no parameters for
long-acting insulins in the residents' records. They should be administering these or at the very least calling
and asking the doctor if they should administer the insulin when they do accuchecks [blood sugar
monitoring]. This [medication error] was not reported to the physician when this occurred by the night nurse
at 6:15 AM. It was not reported until about 11:30 in the morning. She came back in when [Assistant Director
of Nursing's name] got hold of her. The staff should have called the doctor when the mistake occurred and
obtained orders then. I can't tell you why she didn't. I'm not sure when the day shift nurse found out about
the error. We did not look at all the residents' receiving insulin when the medication error was made. I didn't
know that I needed to evaluate anyone else after [Staff A's name] made the mistake. They just don't know
or have any common sense that would make them call the doctor. They clearly don't understand the
difference between long and short acting insulins. I guess we need to train them.
During an interview on 6/19/2023 at 11:41 AM, Staff A, LPN, stated, I was helping out that night. I usually
work days and usually work the LTC [long term care] unit and picked up a shift. I read her order and she
had two different insulins. One insulin looked like it was in the wrong bag. I thought it was too much insulin, I
gave it, the long acting the Lantus. Then I reread the order after the resident told me she didn't get that kind
until the night. After that I just waited for the day nurse. I did not notify the doctor. I guess I just didn't think it
was necessary and then I spoke with the day nurse, and she didn't say to call the doctor. She said, well we
will just wait and see what her blood sugar does. I should have called. [Assistant Director of Nursing's
name] messaged me and asked about it. I told him what happened and came in to write the progress note
and I called the doctor then. I explained what happened. He did not give any new orders because the
resident was leaving with her daughter, who was taking her to the hospital. I did tell the oncoming nurse
and she didn't seem too concerned because it was a long-acting insulin. She did not tell me to call the
doctor before I left. The resident said to me after I told her what I administered that she took that [Lantus
insulin] at night not in the morning. I double checked the MAR and saw she was right. She had been given
her Lantus the evening before. I just didn't think about it at all.
During a telephone interview on 6/19/2023 at 11:50 AM, Staff B, RN, stated, I came on shift and the night
shift nurse told me she had given the wrong insulin. I didn't tell her to call the doctor, said she notified him.
At about 8 AM [Resident #1's name] was going to breakfast, and she told me about the med error. At that
time, she was complaining she was weak and had a stomachache. I didn't check her blood sugar then; she
was going to eat, and I told her if she didn't feel better to let me know. When she was coming back from
breakfast, she was still feeling that way, so I got her to lay down. I went to do something else with another
resident and then her daughter was on the phone, and I spoke to her. She was very upset, so I talked to
her. After I got off the phone, I checked her insulin, and it was 301 at that time. After that, I spoke with her
daughter and her daughter insisted I not give her anything more and stated she would take her to the ER
because she didn't want her to go to anywhere but [hospital's name]. She told another nurse she was
having chest pain sometime around then, but I wasn't worried about chest pain. I don't know why. I guess
because her daughter was going to take her to the ER. I did not call the doctor about the chest pain or any
other symptoms
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 18 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
that she had. I should have called him. He was going to send her out and they would take her to [hospital's
name] and I knew her daughter didn't want her to go there and so I just didn't think to call and notify him. I
did not think to call 911 and let the resident or daughter refuse to go to the hospital. I should have.
During a telephone interview on 6/19/2023 at 12:10 PM, the MD stated, I was not notified of this error when
it occurred. I absolutely should have been notified and I would have ordered more frequent blood sugars to
determine if there was a pattern of hypoglycemia [low blood sugar] and we would have been able to treat
any potential hypoglycemic events. I was not aware that she had any episodes of chest pain or pressure,
fatigue or abdominal discomfort. Again, I should have been notified and I would have had them send her to
the hospital.
During a telephone interview on 6/19/2023 at 12:30 PM, Resident #1 stated, I was having chest pain,
sweating, and nausea when I left [NAME] Pointe because I was given the wrong insulin. So, my daughter
brought me to [hospital's name] ED [Emergency Department]. I am still in the hospital now. But I'm not
feeling too good. I don't think that my blood sugar was too low when I got to the hospital. I told them that
they were giving me the wrong kind of insulin, but they didn't listen. They did not check my blood sugar after
they did that. I told them when I went to breakfast that I wasn't feeling good, but they didn't listen. After
breakfast, I told them again that I was having chest pains and feeling dizzy and nauseous, but they didn't
listen until my daughter called. After that is when they checked on me.
During an interview on 6/19/2023 at 1:41 PM, the Assistant Director of Nursing (ADON) stated, I was on
call that day and don't remember what exact time I was called. Staff told me that the resident was being
taken to the emergency room and that there had been a med error and what the error was. That the error
was that Lantus had been given instead of the ordered insulin. I contacted the nurse, [Staff A's name],
asked what happened. She explained everything. She did let me know that she had not contacted the
doctor or completed any documentation. I told her that she needed to make sure she had an SBAR and MD
notification documented. She stated she would come here immediately and come work on it. She should
have immediately called the physician. I found out that the patient had chest pain also and that's why the
family was so upset. We should have documented any symptoms and called the physician when she was
having chest pain, and got an order to leave to the ED. If her daughter refused, because she didn't want to
go to the nearest hospital, then she refused. But we did not call and get orders to send her out of the facility
to the hospital and we should have.
During an interview conducted on 6/19/2023 at 3:20 PM, Staff I, Director of Nursing (DON), stated, Each
time 11 is documented the medication was not given per parameters, the nurses did not administer the
long-acting insulin. Reviewing the orders, I see that there are no parameters to hold the medication and the
insulin should have been administered. They were not following doctors' orders. They were not following the
policies for medication administration and holding medications. They should have called the doctor if they
were concerned about administering the medications. I have no idea why they would have held the insulin. I
guess this is an education thing. They just don't know any better. I just don't know why they did this.
During a telephone interview on 7/5/2023 at 2:10 PM, Staff C, LPN, stated, I was not really given a good
in-service about insulin or medication errors. She told me to sign a piece of paper, the other DON. I did not
get any text messages. I didn't know that we shouldn't hold the insulin, that we needed parameters to hold
it. My understanding was that anything under 150, we should not administer the insulin. I guess I just
assumed that from the sliding scales maybe. Also, I was holding some
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 19 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
insulin when residents didn't want to take it because they knew that would make them drop lower and I was
documenting it as 11, which is wrong, and they told me in the in-service today. I did come in today and have
the in-service with the DON. We went over neglect, insulin long and short acting, parameters with short
acting, that we will call doctors if we have concerns, changes in condition, medication errors and making
sure we notify doctors and families. We did an insulin demonstration too.
During a telephone interview on 7/5/2023 at 2:35 PM, Staff D, LPN, stated, I did hold insulin for low blood
sugars. Just through the years I was told that if the blood sugars are less than 150 not to administer the
insulin because it would drop it lower. I did not have a doctor's order to hold the insulin and I did not call
when I wasn't giving the insulin. I should have administered the insulin if there were no parameters to hold
it. I was not following doctors' orders when I held those insulins if there were no parameters written in the
orders.
During an interview on 7/6/2023 at 10:35 AM, the MD stated, I was not aware that nurses were holding
long-acting insulins outside of my written parameters. I write an order for accuchecks and to be notified if
they are below 60 or above 400. I do not write specific hold orders. I expect them to administer the insulin. If
they are symptomatic meaning, they are dizzy, lightheaded, I expect to be called and notified. I do expect
the staff to inform me anytime they hold medications. The risk of not administering long-acting insulin would
most obviously be hyperglycemia, going into HHNK if they have any infection brewing. It is and can be
catastrophic in the right setting. Residents would need to get hospitalized if the hyperglycemia were severe
enough, they risk dehydration with persistent hyperglycemia and diabetics poorly controlled are at risk for
worsening kidney failure, electrolyte abnormalities, worsening eyesight, worsening peripheral neuropathy,
coma and sometimes death. We need to provide this education and training to the nurses.
During a telephone interview on 7/6/2023 at 11:00 AM, Staff E, LPN, stated, I was holding the Levemir and
Lantus and would document that insulin was not needed because blood sugars were low. They weren't
really low, not in the 50s, but below 150. I didn't know I wasn't supposed to do that. I did not call or notify the
doctor when I held those. I should have. There were not any parameters to hold the insulin. I was not
following the doctors' orders. I should have followed the orders. I thought I was doing the right thing. I would
never want to hurt anyone at all. I was provided one on one education about neglect, long and short acting
insulin, what parameters are for holding insulin, calling doctors with any time we need to hold medications,
or they are refused, changes in condition notifications, medication errors and reporting them to doctors. We
had to do an insulin and five rights of medication administration demonstration for the DON.
During a telephone interview on 7/6/2023 at 11:30 AM, Staff F, LPN, stated, I did hold insulin when the
blood sugars were low, less than 150. I was taught that we don't give insulin for anything less than 150. I
don't think that the orders had any parameters from the doctor. I did not call the doctor and I would have
documented if they had any symptoms. There were no orders to hold the insulin, I was not following
doctors' orders. I should have given the insulin and followed the orders. I have been in-serviced today on
neglect, the five rights of medication adminis[TRUNCATED]
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 20 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Administer the facility in a manner that enables it to use its resources effectively and efficiently.
Level of Harm - Immediate
jeopardy to resident health or
safety
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews with a resident and staff, resident record reviews and review of the facility policies and
procedures, the facility administration failed to use its resources effectively and efficiently to attain or
maintain the highest practicable physical wellbeing of each resident when not assuming full responsibility
for the day-to-day operations of the facility. The facility failed to ensure residents were provided physician
ordered insulin for 6 of 7 residents, Residents #1, #2, #3, #4, #5 and #6. Resident #1 was administered the
wrong insulin and Residents #2, #3, #4, #5, and #6 were not administered physician ordered long-acting
insulin. The body must have insulin working 24 hours a day. If there is no long-acting insulin administered
and rapid acting insulin is not given within the past 3-4 hours, it is likely that the body will make ketones and
will be at risk of developing life-threatening diabetic ketoacidosis (DKA) or Hyperglycemic Hyperosmolar
Nonketotic Syndrome (HHNS). Extremely high blood glucose can lead to Hyperosmolar Hyperglycemic
Nonketotic Coma (HHNK), a life-threatening complication of uncontrolled diabetes mellitus. This syndrome
is characterized by severe hyperglycemia, a marked increase in serum osmolality, and clinical evidence of
dehydration without significant accumulation of keto acids, which can result when diabetic medications
aren't taken as directed. DKA is caused by an overload of ketones present in your blood. When the cells
don't get the glucose they need for energy, the body begins to burn fat for energy, which produces ketones.
Ketones are chemicals that the body creates when it breaks down fat to use for energy. DKA is a
life-threatening problem that affects people with diabetes. It occurs when the body starts breaking down fat
at a rate that is much too fast. The liver processes the fat into a fuel called ketones, which causes the blood
to become acidic.
Residents Affected - Some
Findings include:
Review of the job description for the Executive Director (Administrator) read, Purpose of Your Job Position:
The Executive Director is responsible for management of the facility in a manner which exemplifies
Raydiant Health Care's standard of operational excellence, to include but not limited to creating an
environment in which employees demonstrate Honesty, Authentic Innovative, Compassion, Diversity, Equity
& Inclusion. The primary purpose of the Executive Director is to direct the day-to-day functions of the facility
in accordance with current federal, state, and local standards, guidelines, and regulations that govern
nursing facilities to ensure that the highest degree of quality care can be provided to our residents at all
times. You are entrusted to provide innovative, responsible healthcare with the creation and implementation
of new ideas and concepts that continually improve systems and processes to achieve superior results. Job
functions: As Executive Director, you are delegated the administrative authority, responsibility, and
accountability necessary for carrying out your assigned duties. Responsible for day-to-day clinical and
administrative activities of the facility, including profit and loss responsibility and ensure compliance with all
state and federal regulations. Supervises Director of Clinical Services, Business Office Manager, Business
Office Coordinator, Director of Admission, Director of Rehabilitation Services, Director of Resident and
Family Services, Director of Therapeutic Recreational Services, Director of Hospitality Services, Director of
Dining Services, Director of Environmental Services, Customer Service Associate. You will also provide
leadership to all facility staff in meeting the goal of providing quality resident care. This job description does
not list all the duties of your job. You may be asked by the supervisors or managers to perform other duties.
You will be evaluated in part based upon your performance of the tasks listed in this job description at
anytime. This job description is not a contract for employment and either you or the employer may terminate
employment at any time for any reason. Duties and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 21 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
Responsibilities . 2. Establish financial and programmatic goals for the facility and conduct an annual
evaluation of goal achievement . 7. Schedule regular meeting with direct report staff to provide supervision,
ensure communication and to monitor facility operations . 9. Maintain and guide the implementation of
facility policies and procedures in compliance with corporate, state, federal, and other regulatory guidelines
. 11. Support and guide the facility's quality improvement process . 23. Adhere to facility policies and
procedures and participate in facility quality improvement and safety programs.
Residents Affected - Some
Review of the job description for Director of Nursing I read, Purpose of Your Job Position . The primary
purpose of your job position is to plan, organize, develop and direct the overall operation of our Nursing
Service Department in accordance with current federal, state, and local standards, guidelines and
regulations that govern our facility and as may be directed by the Executive Director to ensure that the
highest degree of quality care is maintained at all times. You are entrusted to provide innovative responsible
healthcare with the creation and implementation of new ideas and concepts that continually improve
systems and processes to achieve superior results. Job Functions: As Director of Nursing I, you are
delegated the administrative authority, responsibility, and accountability necessary for carrying out your
assigned duties. Responsible for planning, organizing, and directing the functions for the nursing
department. You will assume the primary role in ensuring the delivery of high quality efficient nursing care.
Supervises Nurse Practitioner, Assistant Director of Nursing, Clinical Nurses, and Nurse Techs. In the
absence of the Executive Director, you are charged with carrying out the resident care policies established
by this facility. This job description does not list all the duties of the job. You may be asked by the
supervisors or managers to perform other duties. Duties and Responsibilities . 5. Set and monitor
achievement of goals and objectives for the nursing department consistent with the established philosophy
and standards of practice. 7. Establish, implement, and continually update competency/skills checklists for
nursing staff . 9. Maintain and guide the implementation of current policies and procedures, which reflect
adherence to corporate and external regulatory guidelines . 11. Establish and monitor compliance with an
effective medical record documentation system . 14. Actively participate in the quality improvement process
for the facility. 15. Participate in and/or provide inservice education sessions.
Review of the medical record for Resident #6 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #6 dated 7/13/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml [milliliter] (Insulin Glargine) inject 10 units subcutaneously in the morning
related to type 2 diabetes mellitus without complications.
Review of the physician orders for Resident #6 dated 7/14/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the Medication Administration Record (MAR) for Resident #6 for the period of 4/1/2023 to
7/5/2023 showed on 4/1/2023 at 6:00 AM, Staff D, LPN (Licensed Practical Nurse) documented 11 (held
per parameters) for Lantus Insulin, 4/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/2/23 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for
Lantus Insulin, 4/3/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/4/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/4/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/5/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/7/2023 at 9:00 PM,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 22 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/8/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/8/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/9/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/10/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/13/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/14/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/17/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at 6:00 AM, Staff, C LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/19/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/21/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/22/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/23/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/23/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/24/2023 at 6:00 AM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/26/2023 at 9:00 PM, Staff, C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/27/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/27/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/28/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/2/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/5/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/6/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/8/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/11/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/12/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/15/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/16/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/24/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/3/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/5/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/6/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Insulin, 6/7/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin,
6/14/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/14/2023 at
9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/19/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/20/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/21/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/21/2023 at 9:00
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 23 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
PM, Staff, D LPN, documented 11 (held per parameters) for Lantus Insulin, 6/22/2023 at 6:00 AM, Staff D,
LPN, documented 11 (held per parameters) for Lantus Insulin, 7/1/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 7/1/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 7/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin.
Residents Affected - Some
Review of the medical record for Resident #4 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #4 dated 3/7/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to Type
2 diabetes mellitus without complications.
Review of the MAR for Resident #4 for the period of 4/1/2023 to 7/5/2023 showed on 4/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/3/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/4/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 4/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/18/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/21/2023 at 9:00
PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/22/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/23/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/26/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/27/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 5/1/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 5/2/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/5/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 5/6/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
5/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/25/2023
at 9:00 PM, Staff A, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/2/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/3/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 6/5/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Levemir Flexpen, 6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 6/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 6/20/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen,
6/21/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/26/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/30/2023 at 9:00
PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 7/1/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #5 documented diagnosis to include type 2 diabetes mellitus.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 24 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Review of the physician orders for Resident #5 dated 4/5/2023 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 45 units subcutaneously every morning and at
bedtime related to type 2 diabetes mellitus without complications.
Review of the MAR for Resident #5 for the period of 4/1/2023 to 7/5/2023 showed on 4/7/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/8/2023 at 8:00 PM, Staff E, LPN,
documented 12 (insulin not required) for Lantus Solostar, 4/9/2023 at 6:00 AM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 4/11/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 4/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required)
for Lantus Solostar, 4/13/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 4/13/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
4/17/2023 at 6:00 AM, Staff F, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/18/2023 at
8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/19/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/21/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/21/2023 at 8:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/22/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/23/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/25/2023 at 8:00 PM, Staff G, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/26/2023 at 6:00 AM, Staff G, LPN,
documented 5 (hold see nurses notes) for Lantus Solostar, 4/27/2023 at 6:00 AM, Staff E, LPN,
documented 11 (held per parameters) for Lantus Solostar, 5/2/2023 at 6:00 AM, Staff E, LPN, documented
11 (held per parameters) for Lantus Solostar, 5/5/2023 at 8:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Solostar, 5/6/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Solostar, 5/11/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 5/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
5/15/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/17/2023 at
6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 5/20/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 6/2/2023 at 8:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 6/3/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Solostar, 6/9/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 6/13/2023 at 6:00 AM, Staff H, LPN, documented 12 (insulin not required)
for Lantus Solostar, 6/15/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Solostar, 6/19/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar,
6/23/2023 at 6:00 AM, Staff H, LPN, documented 9 (other see nursing note) for Lantus Solostar, 6/30/2023
at 8:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Solostar, 7/1/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar.
Review of the medical record for Resident #2 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #2 dated 4/6/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the MAR for Resident #2 for the period of 6/1/2023 to 6/19/2023 showed on 6/6/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/14/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 25 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Review of the medical record for Resident #3 documented diagnosis to include type 2 diabetes mellitus.
Level of Harm - Immediate
jeopardy to resident health or
safety
Review of the physician orders for Resident #3 dated 3/10/2023 read, Insulin Glargine Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 35 units subcutaneously at bedtime related to
Type 2 diabetes mellitus without complications.
Residents Affected - Some
Review of the MAR for Resident #3 for the period of 5/1/2023 to 6/19/2023 showed on 5/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/6/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/20/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/29/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/4/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/8/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin.
Review of the medical record for Resident #1 documented diagnosis to include type 2 diabetes mellitus and
diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Aspart Flexpen Subcutaneous
Solution Pen- injector 100 unit/ml (Insulin Aspart) inject 21 units subcutaneously before meals related to
type 2 diabetes mellitus with diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Glargine Solostar
Subcutaneous Solution Pen- injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at
bedtime related to type 2 diabetes mellitus with diabetic neuropathy.
Review of the MAR for Resident #1 for the period of 6/1/2023 to 6/4/2023 showed on 6/4/2023 at 6:00 AM,
Staff A, LPN, documented 9 (other see nurses notes).
Review of the nursing progress notes did not reveal a progress note on 6/4/2023 for 6:00 AM written by
Staff A, LPN.
Review of the change of condition SBAR (Situation, Background, Assessment and Recommendation)
dated 6/4/2023 at 2:13 PM for Resident #1 read, A. Situation: 1 . gave Lantus instead of NovoLog this AM
[morning]. 2. This started on: 06/04/2023 . C. Review and Notify. 1. Primary clinician notified: [Doctor's
name]. 2. Date and Time notified: 06/04/2023 14:20 [2:20 PM]. 3. Recommendations of Primary Clinician (if
any): no new orders . 7. Nursing Notes (for additional information on the Change in Condition): Notified MD
[Medical Doctor], no new orders, informed him that family chose to take resident to ER [Emergency Room]
in Gainesville.
Review of the nursing progress note authored by Staff B, Registered Nurse (RN), dated 6/4/2023 at
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 26 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
5:33 PM for Resident #1 read, Resident stated that the night nurse had given her the wrong insulin. She
stated that she told the nurse that it was the wrong insulin before the nurse gave it to her. Resident then
complained of having chest pains and a stomachache around 0800 [8:00 AM]. I checked the residents [Sic.]
blood sugar and it was 301. The residents [Sic.] daughter called facility upset and stated that no one
notified her of the medication error and that she was going to come take her mother to [hospital's name and
city of location] because she is too high risk to go to [local hospital's name]. The daughter told me to not
give her mother anymore insulin or medication until she takes her to [hospital's name]. The daughter also
stated that she was going to call the police and her attorney. At approximately 1130 [11:30 AM] the
daughter arrived with a police officer [Resident #1's name] walked out of the facility with her daughter at
approximately 1200 [noon].
During an interview on 6/19/2023 at 11:00 AM, Staff I, Director of Nursing (DON), stated, Insulin is a
high-risk medication that an error can cause problems with low blood sugars or with high blood sugars if
they administer too much, the wrong kind or none. I was not aware that nurses were not administering
insulin and documenting that it was being held because of parameters. There are no parameters for
long-acting insulins in the residents' records. They should be administering these or at the very least calling
and asking the doctor if they should administer the insulin when they do accuchecks [blood sugar
monitoring]. This [medication error] was not reported to the physician when this occurred by the night nurse
at 6:15 AM. It was not reported until about 11:30 in the morning. She came back in when [Assistant Director
of Nursing's name] got hold of her. The staff should have called the doctor when the mistake occurred and
obtained orders then. I can't tell you why she didn't. I'm not sure when the day shift nurse found out about
the error. We did not look at all the residents' receiving insulin when the medication error was made. I didn't
know that I needed to evaluate anyone else after [Staff A's name] made the mistake. They just don't know
or have any common sense that would make them call the doctor. They clearly don't understand the
difference between long and short acting insulins. I guess we need to train them.
During an interview on 6/19/2023 at 11:41 AM, Staff A, LPN, stated, I was helping out that night. I usually
work days and usually work the LTC [long term care] unit and picked up a shift. I read her order and she
had two different insulins. One insulin looked like it was in the wrong bag. I thought it was too much insulin, I
gave it, the long acting the Lantus. Then I reread the order after the resident told me she didn't get that kind
until the night. After that I just waited for the day nurse. I did not notify the doctor. I guess I just didn't think it
was necessary and then I spoke with the day nurse, and she didn't say to call the doctor. She said, well we
will just wait and see what her blood sugar does. I should have called. [Assistant Director of Nursing's
name] messaged me and asked about it. I told him what happened and came in to write the progress note
and I called the doctor then. I explained what happened. He did not give any new orders because the
resident was leaving with her daughter, who was taking her to the hospital. I did tell the oncoming nurse
and she didn't seem too concerned because it was a long-acting insulin. She did not tell me to call the
doctor before I left. The resident said to me after I told her what I administered that she took that [Lantus
insulin] at night not in the morning. I double checked the MAR and saw she was right. She had been given
her Lantus the evening before. I just didn't think about it at all.
During a telephone interview on 6/19/2023 at 11:50 AM, Staff B, RN, stated, I came on shift and the night
shift nurse told me she had given the wrong insulin. I didn't tell her to call the doctor, said she notified him.
At about 8 AM [Resident #1's name] was going to breakfast, and she told me about the med error. At that
time, she was complaining she was weak and had a stomachache. I didn't check her blood sugar then; she
was going to eat, and I told her if she didn't feel better to let
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 27 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0835
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
me know. When she was coming back from breakfast, she was still feeling that way, so I got her to lay
down. I went to do something else with another resident and then her daughter was on the phone, and I
spoke to her. She was very upset, so I talked to her. After I got off the phone, I checked her insulin, and it
was 301 at that time. After that, I spoke with her daughter and her daughter insisted I not give her anything
more and stated she would take her to the ER because she didn't want her to go to anywhere but
[hospital's name]. She told another nurse she was having chest pain sometime around then, but I wasn't
worried about chest pain. I don't know why. I guess because her daughter was going to take her to the ER. I
did not call the doctor about the chest pain or any other symptoms that she had. I should have called him.
He was going to send her out and they would take her to [hospital's name] and I knew her daughter didn't
want her to go there and so I just didn't think to call and notify him. I did not think to call 911 and let the
resident or daughter refuse to go to the hospital. I should have.
During a telephone interview on 6/19/2023 at 12:10 PM, the MD stated, I was not notified of this error when
it occurred. I absolutely should have been notified and I would have ordered more frequent blood sugars to
determine if there was a pattern of hypoglycemia [low blood sugar] and we would have been able to treat
any potential hypoglycemic events. I was not aware that she had any episodes of chest pain or pressure,
fatigue or abdominal discomfort. Again, I should have been notified and I would have had them send her to
the hospital.
During a telephone interview on 6/19/2023 at 12:30 PM, Resident #1 stated, I was having chest pain,
sweating, and nausea when I left [NAME] Pointe because I was given the wrong insulin. So, my daughter
brought me to [hospital's name] ED [Emergency Department]. I am still in the hospital now. But I'm not
feeling too good. I don't think that my blood sugar was too low when I got to the hospital. I told them that
they were giving me the wrong kind of insulin, but they didn't listen. They did not check my blood sugar after
they did that. I told them when I went to breakfast that I wasn't feeling good, but they didn't listen. After
breakfast, I told them again that I was having chest pains and feeling dizzy and nauseous, but they didn't
listen until my daughter called. After that is when they checked on me.
During an interview on 6/19/2023 at 1:41 PM, the Assistant Director of Nursing (ADON) stated, I was on
call that day and don't remember what exact time I was called. Staff told me that the resident was being
taken to the emergency room and that there had been a med error and what the error was. That the error
was that Lantus had been given instead of the ordered insulin. I contacted the nurse, [Staff A's name],
asked what happened. She explained everything. She did let me know that she had not contacted the
doctor or completed any documentation. I told her that she needed to make sure she had an SBAR and MD
notification documented. She stated she would come here immediately and come work on it. She should
have immediately called the physician. I found out that the patient had chest pain also and that's why the
family was so upset. We should have documented any symptoms and called the physician when she was
having chest pain, and got an order to leave to the ED. If her daughter refused, because she didn't want
[TRUNCATED]
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 28 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Set up an ongoing quality assessment and assurance group to review quality deficiencies and develop
corrective plans of action.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interviews with a resident and staff, resident record reviews and review of the facility policies and
procedures, the facility failed to develop and implement an appropriate plan of action to correct an identified
quality deficiency when it was identified Resident #1 was administered a long-acting-insulin when a short
acting insulin was ordered by the physician, and failed to identity 5 of 7 residents, Residents #2, #3, #4, #5,
#6, were not administered physician ordered long-acting-insulin. The body must have insulin working 24
hours a day. If there is no long-acting insulin administered and rapid acting insulin is not given within the
past 3-4 hours, it is likely that the body will make ketones and will be at risk of developing life-threatening
diabetic ketoacidosis (DKA) or Hyperglycemic Hyperosmolar Nonketotic Syndrome (HHNS). Extremely high
blood glucose can lead to Hyperosmolar Hyperglycemic Nonketotic Coma (HHNK), a life-threatening
complication of uncontrolled diabetes mellitus. This syndrome is characterized by severe hyperglycemia, a
marked increase in serum osmolality, and clinical evidence of dehydration without significant accumulation
of keto acids, which can result when diabetic medications aren't taken as directed. DKA is caused by an
overload of ketones present in your blood. When the cells don't get the glucose they need for energy, the
body begins to burn fat for energy, which produces ketones. Ketones are chemicals that the body creates
when it breaks down fat to use for energy. DKA is a life-threatening problem that affects people with
diabetes. It occurs when the body starts breaking down fat at a rate that is much too fast. The liver
processes the fat into a fuel called ketones, which causes the blood to become acidic.
Findings include:
Review of the medical record for Resident #1 documented diagnosis to include type 2 diabetes mellitus and
diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Aspart Flexpen Subcutaneous
Solution Pen- injector 100 unit/ml (Insulin Aspart) inject 21 units subcutaneously before meals related to
type 2 diabetes mellitus with diabetic neuropathy.
Review of the physician orders for Resident #1 dated 5/26/2023 read, Insulin Glargine Solostar
Subcutaneous Solution Pen- injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at
bedtime related to type 2 diabetes mellitus with diabetic neuropathy.
Review of the MAR for Resident #1 for the period of 6/1/2023 to 6/4/2023 showed on 6/4/2023 at 6:00 AM,
Staff A, LPN, documented 9 (other see nurses notes).
Review of the nursing progress notes did not reveal a progress note on 6/4/2023 for 6:00 AM written by
Staff A, LPN.
Review of the change of condition SBAR (Situation, Background, Assessment and Recommendation)
dated 6/4/2023 at 2:13 PM for Resident #1 read, A. Situation: 1 . gave Lantus instead of NovoLog this AM
[morning]. 2. This started on: 06/04/2023 . C. Review and Notify. 1. Primary clinician notified: [Doctor's
name]. 2. Date and Time notified: 06/04/2023 14:20 [2:20 PM]. 3. Recommendations of Primary Clinician (if
any): no new orders . 7. Nursing Notes (for additional information on the Change in Condition): Notified MD
[Medical Doctor], no new orders, informed him that family chose to take resident to ER [Emergency Room]
in Gainesville.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 29 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Review of the nursing progress note authored by Staff B, Registered Nurse (RN), dated 6/4/2023 at 5:33
PM for Resident #1 read, Resident stated that the night nurse had given her the wrong insulin. She stated
that she told the nurse that it was the wrong insulin before the nurse gave it to her. Resident then
complained of having chest pains and a stomachache around 0800 [8:00 AM]. I checked the residents [Sic.]
blood sugar and it was 301. The residents [Sic.] daughter called facility upset and stated that no one
notified her of the medication error and that she was going to come take her mother to [hospital's name and
city of location] because she is too high risk to go to [local hospital's name]. The daughter told me to not
give her mother anymore insulin or medication until she takes her to [hospital's name]. The daughter also
stated that she was going to call the police and her attorney. At approximately 1130 [11:30 AM] the
daughter arrived with a police officer [Resident #1's name] walked out of the facility with her daughter at
approximately 1200 [noon].
Review of the medical record for Resident #6 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #6 dated 7/13/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml [milliliter] (Insulin Glargine) inject 10 units subcutaneously in the morning
related to type 2 diabetes mellitus without complications.
Review of the physician orders for Resident #6 dated 7/14/2022 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 25 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the Medication Administration Record (MAR) for Resident #6 for the period of 4/1/2023 to
7/5/2023 showed on 4/1/2023 at 6:00 AM, Staff D, LPN (Licensed Practical Nurse) documented 11 (held
per parameters) for Lantus Insulin, 4/1/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/2/23 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for
Lantus Insulin, 4/3/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/4/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/4/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/5/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/7/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/8/2023 at 6:00 AM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/9/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/10/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/13/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/13/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/14/2023 at 6:00 AM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/17/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/18/2023 at 6:00 AM, Staff, C LPN, documented
11 (held per parameters) for Lantus Insulin, 4/18/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 4/19/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 4/21/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/22/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/23/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/23/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 4/24/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 4/26/2023 at 9:00 PM, Staff, C, LPN, documented
11 (held per parameters) for
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 30 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Lantus Insulin, 4/27/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 4/27/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin,
4/28/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/1/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/2/2023 at 6:00 AM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/3/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/5/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/6/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/7/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/8/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/11/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/11/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/12/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/15/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/24/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/3/2023 at 6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 6/5/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin,
6/6/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/6/2023 at
9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/7/2023 at 6:00 AM, Staff
D, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/14/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/14/2023 at 9:00 PM, Staff D, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/19/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/20/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/21/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Insulin, 6/21/2023 at 9:00 PM, Staff, D LPN, documented 11 (held per parameters) for Lantus Insulin,
6/22/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Insulin, 7/1/2023 at
6:00 AM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 7/1/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 7/3/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin.
Review of the medical record for Resident #4 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #4 dated 3/7/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to Type
2 diabetes mellitus without complications.
Review of the MAR for Resident #4 for the period of 4/1/2023 to 7/5/2023 showed on 4/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/3/2023 at 9:00 PM, Staff C,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/4/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 4/7/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen, 4/8/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 4/9/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 4/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 4/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
4/17/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/18/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 31 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
Levemir Flexpen, 4/21/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 4/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen,
4/23/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/26/2023
at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 4/27/2023 at 9:00
PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/1/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 5/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 5/5/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen, 5/6/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/22/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/25/2023 at 9:00 PM, Staff A, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 5/30/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Levemir Flexpen, 6/2/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters)
for Levemir Flexpen, 6/3/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir
Flexpen, 6/5/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen,
6/6/2023 at 9:00 PM, Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/7/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/19/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/20/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/21/2023 at 9:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 6/26/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 6/30/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Levemir Flexpen, 7/1/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #5 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #5 dated 4/5/2023 read, Lantus Solostar Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 45 units subcutaneously every morning and at
bedtime related to type 2 diabetes mellitus without complications.
Review of the MAR for Resident #5 for the period of 4/1/2023 to 7/5/2023 showed on 4/7/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/8/2023 at 8:00 PM, Staff E, LPN,
documented 12 (insulin not required) for Lantus Solostar, 4/9/2023 at 6:00 AM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 4/11/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 4/12/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required)
for Lantus Solostar, 4/13/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus
Solostar, 4/13/2023 at 8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
4/17/2023 at 6:00 AM, Staff F, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/18/2023 at
8:00 PM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/19/2023 at 6:00 AM,
Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar, 4/21/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/21/2023 at 8:00 PM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/22/2023 at 6:00 AM, Staff D, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/23/2023 at 6:00 AM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/25/2023 at 8:00 PM, Staff G, LPN,
documented 11 (held per parameters) for Lantus Solostar, 4/26/2023 at 6:00 AM, Staff G, LPN,
documented 5 (hold see nurses notes) for Lantus Solostar, 4/27/2023 at 6:00 AM, Staff E, LPN,
documented 11 (held per parameters) for Lantus Solostar, 5/2/2023 at 6:00 AM, Staff E, LPN, documented
11 (held per parameters) for Lantus Solostar, 5/5/2023 at
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 32 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
8:00 PM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 5/6/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 5/11/2023 at 6:00 AM, Staff E,
LPN, documented 12 (insulin not required) for Lantus Solostar, 5/12/2023 at 6:00 AM, Staff E, LPN,
documented 12 (insulin not required) for Lantus Solostar, 5/15/2023 at 8:00 PM, Staff E, LPN, documented
12 (insulin not required) for Lantus Solostar, 5/17/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin
not required) for Lantus Solostar, 5/20/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per
parameters) for Lantus Solostar, 6/2/2023 at 8:00 PM, Staff D, LPN, documented 11 (held per parameters)
for Lantus Solostar, 6/3/2023 at 6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus
Solostar, 6/9/2023 at 6:00 AM, Staff E, LPN, documented 12 (insulin not required) for Lantus Solostar,
6/13/2023 at 6:00 AM, Staff H, LPN, documented 12 (insulin not required) for Lantus Solostar, 6/15/2023 at
6:00 AM, Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 6/19/2023 at 6:00 AM,
Staff D, LPN, documented 11 (held per parameters) for Lantus Solostar, 6/23/2023 at 6:00 AM, Staff H,
LPN, documented 9 (other see nursing note) for Lantus Solostar, 6/30/2023 at 8:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Solostar, 7/1/2023 at 6:00 AM, Staff D, LPN, documented
11 (held per parameters) for Lantus Solostar.
Review of the medical record for Resident #2 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #2 dated 4/6/2023 read, Levemir Flexpen Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Detemir) inject 35 units subcutaneously at bedtime related to type
2 diabetes mellitus without complications.
Review of the MAR for Resident #2 for the period of 6/1/2023 to 6/19/2023 showed on 6/6/2023 at 9:00 PM,
Staff D, LPN, documented 11 (held per parameters) for Levemir Flexpen, 6/14/2023 at 9:00 PM, Staff D,
LPN, documented 11 (held per parameters) for Levemir Flexpen.
Review of the medical record for Resident #3 documented diagnosis to include type 2 diabetes mellitus.
Review of the physician orders for Resident #3 dated 3/10/2023 read, Insulin Glargine Subcutaneous
Solution Pen-injector 100 unit/ml (Insulin Glargine) inject 35 units subcutaneously at bedtime related to
Type 2 diabetes mellitus without complications.
Review of the MAR for Resident #3 for the period of 5/1/2023 to 6/19/2023 showed on 5/1/2023 at 9:00 PM,
Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 5/6/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 5/7/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 5/10/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 5/11/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin, 5/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin,
5/20/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 5/29/2023 at
9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/4/2023 at 9:00 PM, Staff
C, LPN, documented 11 (held per parameters) for Lantus Insulin, 6/2/2023 at 9:00 PM, Staff C, LPN,
documented 11 (held per parameters) for Lantus Insulin, 6/8/2023 at 9:00 PM, Staff C, LPN, documented
11 (held per parameters) for Lantus Insulin, 6/12/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per
parameters) for Lantus Insulin, 6/13/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters)
for Lantus Insulin, 6/16/2023 at 9:00 PM, Staff C, LPN, documented 11 (held per parameters) for Lantus
Insulin.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 33 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
During an interview on 6/19/2023 at 11:00 AM, Staff I, Director of Nursing (DON), stated, Insulin is a
high-risk medication that an error can cause problems with low blood sugars or with high blood sugars if
they administer too much, the wrong kind or none. I was not aware that nurses were not administering
insulin and documenting that it was being held because of parameters. There are no parameters for
long-acting insulins in the residents' records. They should be administering these or at the very least calling
and asking the doctor if they should administer the insulin when they do accuchecks [blood sugar
monitoring]. This [medication error] was not reported to the physician when this occurred by the night nurse
at 6:15 AM. It was not reported until about 11:30 in the morning. She came back in when [Assistant Director
of Nursing's name] got hold of her. The staff should have called the doctor when the mistake occurred and
obtained orders then. I can't tell you why she didn't. I'm not sure when the day shift nurse found out about
the error. We did not look at all the residents' receiving insulin when the medication error was made. I didn't
know that I needed to evaluate anyone else after [Staff A's name] made the mistake. They just don't know
or have any common sense that would make them call the doctor. They clearly don't understand the
difference between long and short acting insulins. I guess we need to train them.
During an interview on 6/19/2023 at 11:41 AM, Staff A, LPN, stated, I was helping out that night. I usually
work days and usually work the LTC [long term care] unit and picked up a shift. I read her order and she
had two different insulins. One insulin looked like it was in the wrong bag. I thought it was too much insulin, I
gave it, the long acting the Lantus. Then I reread the order after the resident told me she didn't get that kind
until the night. After that I just waited for the day nurse. I did not notify the doctor. I guess I just didn't think it
was necessary and then I spoke with the day nurse, and she didn't say to call the doctor. She said, well we
will just wait and see what her blood sugar does. I should have called. [Assistant Director of Nursing's
name] messaged me and asked about it. I told him what happened and came in to write the progress note
and I called the doctor then. I explained what happened. He did not give any new orders because the
resident was leaving with her daughter, who was taking her to the hospital. I did tell the oncoming nurse
and she didn't seem too concerned because it was a long-acting insulin. She did not tell me to call the
doctor before I left. The resident said to me after I told her what I administered that she took that [Lantus
insulin] at night not in the morning. I double checked the MAR and saw she was right. She had been given
her Lantus the evening before. I just didn't think about it at all.
During a telephone interview on 6/19/2023 at 11:50 AM, Staff B, RN, stated, I came on shift and the night
shift nurse told me she had given the wrong insulin. I didn't tell her to call the doctor, said she notified him.
At about 8 AM [Resident #1's name] was going to breakfast, and she told me about the med error. At that
time, she was complaining she was weak and had a stomachache. I didn't check her blood sugar then; she
was going to eat, and I told her if she didn't feel better to let me know. When she was coming back from
breakfast, she was still feeling that way, so I got her to lay down. I went to do something else with another
resident and then her daughter was on the phone, and I spoke to her. She was very upset, so I talked to
her. After I got off the phone, I checked her insulin, and it was 301 at that time. After that, I spoke with her
daughter and her daughter insisted I not give her anything more and stated she would take her to the ER
because she didn't want her to go to anywhere but [hospital's name]. She told another nurse she was
having chest pain sometime around then, but I wasn't worried about chest pain. I don't know why. I guess
because her daughter was going to take her to the ER. I did not call the doctor about the chest pain or any
other symptoms that she had. I should have called him. He was going to send her out and they would take
her to [hospital's name] and I knew her daughter didn't want her to go there and so I just
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 34 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
didn't think to call and notify him. I did not think to call 911 and let the resident or daughter refuse to go to
the hospital. I should have.
During a telephone interview on 6/19/2023 at 12:10 PM, the MD stated, I was not notified of this error when
it occurred. I absolutely should have been notified and I would have ordered more frequent blood sugars to
determine if there was a pattern of hypoglycemia [low blood sugar] and we would have been able to treat
any potential hypoglycemic events. I was not aware that she had any episodes of chest pain or pressure,
fatigue or abdominal discomfort. Again, I should have been notified and I would have had them send her to
the hospital.
During a telephone interview on 6/19/2023 at 12:30 PM, Resident #1 stated, I was having chest pain,
sweating, and nausea when I left [NAME] Pointe because I was given the wrong insulin. So, my daughter
brought me to [hospital's name] ED [Emergency Department]. I am still in the hospital now. But I'm not
feeling too good. I don't think that my blood sugar was too low when I got to the hospital. I told them that
they were giving me the wrong kind of insulin, but they didn't listen. They did not check my blood sugar after
they did that. I told them when I went to breakfast that I wasn't feeling good, but they didn't listen. After
breakfast, I told them again that I was having chest pains and feeling dizzy and nauseous, but they didn't
listen until my daughter called. After that is when they checked on me.
During an interview on 6/19/2023 at 1:41 PM, the Assistant Director of Nursing (ADON) stated, I was on
call that day and don't remember what exact time I was called. Staff told me that the resident was being
taken to the emergency room and that there had been a med error and what the error was. That the error
was that Lantus had been given instead of the ordered insulin. I contacted the nurse, [Staff A's name],
asked what happened. She explained everything. She did let me know that she had not contacted the
doctor or completed any documentation. I told her that she needed to make sure she had an SBAR and MD
notification documented. She stated she would come here immediately and come work on it. She should
have immediately called the physician. I found out that the patient had chest pain also and that's why the
family was so upset. We should have documented any symptoms and called the physician when she was
having chest pain, and got an order to leave to the ED. If her daughter refused, because she didn't want to
go to the nearest hospital, then she refused. But we did not call and get orders to send her out of the facility
to the hospital and we should have.
During an interview conducted on 6/19/2023 at 3:20 PM, Staff I, Director of Nursing (DON), stated, Each
time 11 is documented the medication was not given per parameters, the nurses did not administer the
long-acting insulin. Reviewing the orders, I see that there are no parameters to hold the medication and the
insulin should have been administered. They were not following doctors' orders. They were not following the
policies for medication administration and holding medications. They should have called the doctor if they
were concerned about administering the medications. I have no idea why they would have held the insulin. I
guess this is an education thing. They just don't know any better. I just don't know why they did this.
During an interview on 7/5/2023 at 10:30 AM, the Administrator stated, I don't know exactly what has been
done. I know that the DON left and that we have a new interim DON. She does know about this. There are
no additional medication observations that have been done. There are no audits that I can find. I have given
you everything that we have done since your last visit. I do have the ultimate responsibility for this along
with the DON. We have not met about what was completed and what was not done. We were going to have
another QAPI on Friday. I don't know if we evaluated residents who needed insulin to see the extent of our
problem. I don't see any audits were completed. I don't see that
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 35 of 36
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105846
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/07/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baya Pointe Nursing and Rehabilitation Center
587 SE Ermine Ave
Lake City, FL 32025
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Immediate
jeopardy to resident health or
safety
Residents Affected - Some
we notified the resident representative or the doctors that residents weren't being given their insulin and we
weren't following doctor's orders. I don't think we notified the medical director. We should have done all of
that.
During an interview on 7/5/2023 at 11:55 AM, Staff J, DON, stated, We don't have any additional training or
education to show you. We don't have any audits of residents who are getting insulin to see if they were
administered their insulin correctly after the medication error for that resident. I do see that staff are still
holding long-acting insulins for parameters that don't exist. There really wasn't any investigation into why
they were doing this that I am able to find. I do see that some staff have been trained in medication
administration and insulin use, but not enough. There are no other medication observations done. There are
only four with one that is a repeated staff, so only three staff have had the medication pass observation
done. I can't find any audits and I'm not sure what was audited. We have called all staff and asked them to
come in to be in-serviced and observed, so we are starting that. I will look at all residents who are on
insulin to see how big a problem we have, to see if it's just a few staff or more than that. I am planning to
reeducate them, and I will do an RCA [Root Cause Analysis] to figure out any other problems we are
having or anything else we might need to do. I literally just started on Friday and didn't realize how little was
completed. There is no reason why the insulins were held on any of the residents. We do not have any
parameters for holding long-acting insulin. There were no physician orders for parameters to hold the
insulin. We should have been following doctors' orders. We should have called the doctors and asked. This
was not done.
During a telephone interview on 7/5/2023 at 2:10 PM, Staff C, LPN, stated, I was not really given a good
in-service about insulin or medication errors. She told me to sign a piece of paper, the other DON. I did not
get any text messages. I didn't know that we shouldn't hold the insulin, that we needed parameters to hold
it. My understanding was that anything under 150, we should not administer the insulin. I guess I just
assumed that from the sliding scales maybe. Also, I was holding some insulin when residents didn't want to
take it because they knew that would make them drop lower and I was documenting it as 11, which is
wrong, and they told me in the in-service today. I did come in today and have the in-service with the DON.
We went over neglect, insulin long and short acting, parameters with short acting, that we will call doctors if
we have concerns, changes in condition, medication errors and making sure we notify doctors and families.
We did an insulin demonstration too.
During a telephone interview on 7/5/2023 at 2:35 PM, Staff D, LPN, stated, I did hold insulin for low blood
sugars. Just through the years I was told that if the blood sugars are less than 150 not to administer the
insulin because it would drop it lower. I did not have a doctor's order to hold the insulin and I did not call
when I wasn't giving the insulin. I should have administered the insulin if there were no parameters to hold
it. I was not following doctors' orders when I held those insulins if there were no parameters written in the
orders.
[TRUNCATED]
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105846
If continuation sheet
Page 36 of 36